Rapamycin Low-Dose Safety Profile in Healthy Elderly

Weekly low-dose rapamycin was well-tolerated in adults over 70, with improved immune function markers.

81 Strong
Design 16
Sample 16
Peer Review 18
Replication 14
Transparency 17

NAD+ Precursors Show Promise in Human Trials

NMN supplementation increased blood NAD+ levels by 40% in middle-aged adults, with improvements in insulin sensitivity.

74 Promising
Design 17
Sample 14
Peer Review 18
Replication 10
Transparency 15

Senolytics Extend Healthspan in Mice by 30%

A combination of dasatinib and quercetin cleared senescent cells in aged mice, resulting in improved physical function and extended healthy lifespan by approximately 30%.

78 Strong
Design 18
Sample 15
Peer Review 17
Replication 12
Transparency 16